AVIPTACARE
LIVE
Serial Number
79319911
Owner
Relief Therapeutics International SAAttorney
Monica Riva TalleyFiling Date
May 31, 2021
AVIPTACARE Trademark
Serial Number: 79319911 • Registration: 6776974
AVIPTACARE is a trademark filed by
Relief Therapeutics International SA
on May 31, 2021. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C
1100 New York Avenue
NW
WASHINGTON
DC 20005
Trademark Details
Filing Date
May 31, 2021
Registration Date
July 5, 2022
Published for Opposition
April 19, 2022
Filing History
NOTIFICATION PROCESSED BY IB
Sep 25, 2022 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Sep 6, 2022 FICS
FINAL DISPOSITION PROCESSED
Sep 6, 2022 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Aug 4, 2022 GPAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 5, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 5, 2022 R.PR
NOTIFICATION PROCESSED BY IB
May 4, 2022 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 19, 2022 NPUB
PUBLISHED FOR OPPOSITION
Apr 19, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 13, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 13, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 30, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 14, 2022 CNSA
ASSIGNED TO EXAMINER
Mar 9, 2022 DOCK
NEW REPRESENTATIVE AT IB RECEIVED
Feb 18, 2022 NREP
ASSIGNED TO EXAMINER
Feb 14, 2022 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 20, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 20, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 20, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 20, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 20, 2022 COAR
APPLICATION FILING RECEIPT MAILED
Sep 18, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 14, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 9, 2021 REPR
